| Dr John Jamoulis Jameson, MD | |
|
725 Concord Ave, Suite 2300, Cambridge, MA 02138-1040 | |
| (617) 499-9933 | |
| (617) 499-9935 |
| Full Name | Dr John Jamoulis Jameson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 39 Years |
| Location | 725 Concord Ave, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770578528 | NPI | - | NPPES |
| 3069354 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 72421 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth's Medical Center | Brighton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward St Elizabeths Medical Center Of Boston Inc | 3476749540 | 17 |
News Archive
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Researchers have found a novel protein marker that can give a rapid and early diagnosis of kidney failure in children undergoing heart surgery, reporting their results in this week's issue of The Lancet.
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.
What if improving academic performance in some of the nation's most disadvantaged and lowest-achieving schools was as easy as planting trees in the schoolyard? It's not that simple, of course, but a new study from the University of Illinois suggests school greening could be part of the solution.
"With half of all men in some developing countries already hooked on cigarettes, the tobacco industry is now courting lucrative new customers - young women," according to a report published Thursday in the CDC's Morbidity and Mortality Weekly Report (MMWR), the Associated Press/Los Angeles Times reports.
› Verified 8 days ago
| Entity Name | Ent Surgery Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518979319 PECOS PAC ID: 6406850460 Enrollment ID: O20060905000412 |
News Archive
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Researchers have found a novel protein marker that can give a rapid and early diagnosis of kidney failure in children undergoing heart surgery, reporting their results in this week's issue of The Lancet.
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.
What if improving academic performance in some of the nation's most disadvantaged and lowest-achieving schools was as easy as planting trees in the schoolyard? It's not that simple, of course, but a new study from the University of Illinois suggests school greening could be part of the solution.
"With half of all men in some developing countries already hooked on cigarettes, the tobacco industry is now courting lucrative new customers - young women," according to a report published Thursday in the CDC's Morbidity and Mortality Weekly Report (MMWR), the Associated Press/Los Angeles Times reports.
› Verified 8 days ago
| Entity Name | Steward St Elizabeths Medical Center Of Boston Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174836852 PECOS PAC ID: 3476749540 Enrollment ID: O20101201000677 |
News Archive
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Researchers have found a novel protein marker that can give a rapid and early diagnosis of kidney failure in children undergoing heart surgery, reporting their results in this week's issue of The Lancet.
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.
What if improving academic performance in some of the nation's most disadvantaged and lowest-achieving schools was as easy as planting trees in the schoolyard? It's not that simple, of course, but a new study from the University of Illinois suggests school greening could be part of the solution.
"With half of all men in some developing countries already hooked on cigarettes, the tobacco industry is now courting lucrative new customers - young women," according to a report published Thursday in the CDC's Morbidity and Mortality Weekly Report (MMWR), the Associated Press/Los Angeles Times reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Jamoulis Jameson, MD 725 Concord Ave, Suite 2300, Cambridge, MA 02138-1040 Ph: (617) 499-9933 | Dr John Jamoulis Jameson, MD 725 Concord Ave, Suite 2300, Cambridge, MA 02138-1040 Ph: (617) 499-9933 |
News Archive
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Researchers have found a novel protein marker that can give a rapid and early diagnosis of kidney failure in children undergoing heart surgery, reporting their results in this week's issue of The Lancet.
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.
What if improving academic performance in some of the nation's most disadvantaged and lowest-achieving schools was as easy as planting trees in the schoolyard? It's not that simple, of course, but a new study from the University of Illinois suggests school greening could be part of the solution.
"With half of all men in some developing countries already hooked on cigarettes, the tobacco industry is now courting lucrative new customers - young women," according to a report published Thursday in the CDC's Morbidity and Mortality Weekly Report (MMWR), the Associated Press/Los Angeles Times reports.
› Verified 8 days ago
Dr. Weiru Shao, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Surgery, Cambridge, MA 02139 Phone: 617-665-2555 | |
Dr. Erik Victor Berg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2555 Fax: 617-665-2825 | |
Pamela F. Diamond, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1611 Cambridge St, Cambridge, MA 02138 Phone: 617-661-5525 Fax: 617-661-5202 | |
Dr. Christian Soneru, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, 308, Cambridge, MA 02138 Phone: 630-334-0855 Fax: 617-354-7961 | |
Dr. Lawrence John Mambrino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 308, Cambridge, MA 02138 Phone: 617-354-1010 Fax: 617-354-7961 | |
Dr. Richard Hillel, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 300 Mount Auburn St, Suite 308, Cambridge, MA 02138 Phone: 617-354-1010 Fax: 617-354-7961 | |
Dr. Andrew Katz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 |